- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 273907, 13 pages
doi:10.1155/2011/273907
Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes
1Department of Rheumatology, General Hospital of Athens “G.Gennimatas”, Mesogion St 154, 11527 Athens, Greece
2Department of Experimental Physiology, School of Medicine, University of Athens, M. Asias 75, 11527 Athens, Greece
Received 1 June 2011; Accepted 14 August 2011
Academic Editor: George Tsokos
Copyright © 2011 Theophanis P. Karageorgas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Theophanis P. Karageorgas, Dimitrios D. Tseronis, and Clio P. Mavragani, “Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus: Association with Distinct Clinical Phenotypes,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 273907, 13 pages, 2011. doi:10.1155/2011/273907